nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralidoxime—BCHE—epilepsy syndrome	0.654	1	CbGaD
Pralidoxime—Hyperventilation—Propofol—epilepsy syndrome	0.00303	0.0134	CcSEcCtD
Pralidoxime—Hyperventilation—Midazolam—epilepsy syndrome	0.00297	0.0131	CcSEcCtD
Pralidoxime—Hyperventilation—Fosphenytoin—epilepsy syndrome	0.00283	0.0125	CcSEcCtD
Pralidoxime—Hyperventilation—Diazepam—epilepsy syndrome	0.00271	0.012	CcSEcCtD
Pralidoxime—Diplopia—Primidone—epilepsy syndrome	0.00262	0.0116	CcSEcCtD
Pralidoxime—Excitement—Valproic Acid—epilepsy syndrome	0.00253	0.0112	CcSEcCtD
Pralidoxime—Hyperventilation—Phenytoin—epilepsy syndrome	0.00246	0.0108	CcSEcCtD
Pralidoxime—Diplopia—Trimethadione—epilepsy syndrome	0.00231	0.0102	CcSEcCtD
Pralidoxime—Hyperventilation—Lamotrigine—epilepsy syndrome	0.00227	0.01	CcSEcCtD
Pralidoxime—Drowsiness—Primidone—epilepsy syndrome	0.00202	0.00892	CcSEcCtD
Pralidoxime—Diplopia—Rufinamide—epilepsy syndrome	0.00201	0.00885	CcSEcCtD
Pralidoxime—Diplopia—Lacosamide—epilepsy syndrome	0.00188	0.00831	CcSEcCtD
Pralidoxime—Diplopia—Clobazam—epilepsy syndrome	0.00183	0.00806	CcSEcCtD
Pralidoxime—Drowsiness—Trimethadione—epilepsy syndrome	0.00178	0.00785	CcSEcCtD
Pralidoxime—Inflammation—Clonazepam—epilepsy syndrome	0.00176	0.00775	CcSEcCtD
Pralidoxime—Inflammation—Phenytoin—epilepsy syndrome	0.00175	0.0077	CcSEcCtD
Pralidoxime—Hyperventilation—Pregabalin—epilepsy syndrome	0.00163	0.00719	CcSEcCtD
Pralidoxime—Muscular weakness—Clobazam—epilepsy syndrome	0.00161	0.00711	CcSEcCtD
Pralidoxime—Haemoglobin—Trimethadione—epilepsy syndrome	0.00161	0.00708	CcSEcCtD
Pralidoxime—Haemorrhage—Trimethadione—epilepsy syndrome	0.0016	0.00704	CcSEcCtD
Pralidoxime—Drowsiness—Phenobarbital—epilepsy syndrome	0.00158	0.00695	CcSEcCtD
Pralidoxime—Diplopia—Propofol—epilepsy syndrome	0.00151	0.00668	CcSEcCtD
Pralidoxime—Agitation—Amobarbital—epilepsy syndrome	0.00151	0.00665	CcSEcCtD
Pralidoxime—Hyperventilation—Gabapentin—epilepsy syndrome	0.00149	0.00659	CcSEcCtD
Pralidoxime—Diplopia—Midazolam—epilepsy syndrome	0.00148	0.00653	CcSEcCtD
Pralidoxime—Diplopia—Levetiracetam—epilepsy syndrome	0.00146	0.00645	CcSEcCtD
Pralidoxime—Diplopia—Fosphenytoin—epilepsy syndrome	0.00141	0.00623	CcSEcCtD
Pralidoxime—Drowsiness—Clobazam—epilepsy syndrome	0.00141	0.00621	CcSEcCtD
Pralidoxime—Diplopia—Vigabatrin—epilepsy syndrome	0.00138	0.00607	CcSEcCtD
Pralidoxime—Diplopia—Diazepam—epilepsy syndrome	0.00135	0.00597	CcSEcCtD
Pralidoxime—Diplopia—Felbamate—epilepsy syndrome	0.00131	0.00578	CcSEcCtD
Pralidoxime—Muscular weakness—Midazolam—epilepsy syndrome	0.00131	0.00576	CcSEcCtD
Pralidoxime—Muscular weakness—Levetiracetam—epilepsy syndrome	0.00129	0.00569	CcSEcCtD
Pralidoxime—Diplopia—Zonisamide—epilepsy syndrome	0.00128	0.00566	CcSEcCtD
Pralidoxime—Drowsiness—Acetazolamide—epilepsy syndrome	0.00126	0.00554	CcSEcCtD
Pralidoxime—Muscular weakness—Fosphenytoin—epilepsy syndrome	0.00125	0.00549	CcSEcCtD
Pralidoxime—Diplopia—Clonazepam—epilepsy syndrome	0.00124	0.00545	CcSEcCtD
Pralidoxime—Diplopia—Phenytoin—epilepsy syndrome	0.00123	0.00542	CcSEcCtD
Pralidoxime—Diplopia—Oxcarbazepine—epilepsy syndrome	0.00122	0.00539	CcSEcCtD
Pralidoxime—Muscular weakness—Diazepam—epilepsy syndrome	0.00119	0.00527	CcSEcCtD
Pralidoxime—Somnolence—Amobarbital—epilepsy syndrome	0.00119	0.00525	CcSEcCtD
Pralidoxime—Diplopia—Carbamazepine—epilepsy syndrome	0.00117	0.00517	CcSEcCtD
Pralidoxime—Muscular weakness—Felbamate—epilepsy syndrome	0.00116	0.0051	CcSEcCtD
Pralidoxime—Somnolence—Primidone—epilepsy syndrome	0.00115	0.00506	CcSEcCtD
Pralidoxime—Drowsiness—Midazolam—epilepsy syndrome	0.00114	0.00503	CcSEcCtD
Pralidoxime—Vision blurred—Rufinamide—epilepsy syndrome	0.00114	0.00502	CcSEcCtD
Pralidoxime—Diplopia—Lamotrigine—epilepsy syndrome	0.00113	0.005	CcSEcCtD
Pralidoxime—Muscular weakness—Zonisamide—epilepsy syndrome	0.00113	0.00499	CcSEcCtD
Pralidoxime—Agitation—Phenobarbital—epilepsy syndrome	0.00113	0.00499	CcSEcCtD
Pralidoxime—Drowsiness—Levetiracetam—epilepsy syndrome	0.00113	0.00497	CcSEcCtD
Pralidoxime—Agitation—Rufinamide—epilepsy syndrome	0.00111	0.0049	CcSEcCtD
Pralidoxime—Muscular weakness—Clonazepam—epilepsy syndrome	0.00109	0.00481	CcSEcCtD
Pralidoxime—Muscular weakness—Phenytoin—epilepsy syndrome	0.00108	0.00478	CcSEcCtD
Pralidoxime—Muscular weakness—Oxcarbazepine—epilepsy syndrome	0.00108	0.00475	CcSEcCtD
Pralidoxime—Vision blurred—Lacosamide—epilepsy syndrome	0.00107	0.00472	CcSEcCtD
Pralidoxime—Drowsiness—Vigabatrin—epilepsy syndrome	0.00106	0.00468	CcSEcCtD
Pralidoxime—Haemoglobin—Propofol—epilepsy syndrome	0.00105	0.00464	CcSEcCtD
Pralidoxime—Haemorrhage—Propofol—epilepsy syndrome	0.00105	0.00462	CcSEcCtD
Pralidoxime—Drowsiness—Diazepam—epilepsy syndrome	0.00104	0.0046	CcSEcCtD
Pralidoxime—Agitation—Lacosamide—epilepsy syndrome	0.00104	0.0046	CcSEcCtD
Pralidoxime—Vision blurred—Clobazam—epilepsy syndrome	0.00104	0.00458	CcSEcCtD
Pralidoxime—Muscular weakness—Carbamazepine—epilepsy syndrome	0.00103	0.00456	CcSEcCtD
Pralidoxime—Agitation—Clobazam—epilepsy syndrome	0.00101	0.00446	CcSEcCtD
Pralidoxime—Somnolence—Trimethadione—epilepsy syndrome	0.00101	0.00445	CcSEcCtD
Pralidoxime—Muscular weakness—Lamotrigine—epilepsy syndrome	0.001	0.00441	CcSEcCtD
Pralidoxime—Drowsiness—Clonazepam—epilepsy syndrome	0.000953	0.0042	CcSEcCtD
Pralidoxime—Drowsiness—Phenytoin—epilepsy syndrome	0.000947	0.00418	CcSEcCtD
Pralidoxime—Haemoglobin—Felbamate—epilepsy syndrome	0.000912	0.00402	CcSEcCtD
Pralidoxime—Haemorrhage—Felbamate—epilepsy syndrome	0.000907	0.004	CcSEcCtD
Pralidoxime—Drowsiness—Carbamazepine—epilepsy syndrome	0.000904	0.00399	CcSEcCtD
Pralidoxime—Agitation—Acetazolamide—epilepsy syndrome	0.000902	0.00398	CcSEcCtD
Pralidoxime—Diplopia—Valproic Acid—epilepsy syndrome	0.000901	0.00397	CcSEcCtD
Pralidoxime—Somnolence—Phenobarbital—epilepsy syndrome	0.000893	0.00394	CcSEcCtD
Pralidoxime—Dizziness—Amobarbital—epilepsy syndrome	0.000885	0.0039	CcSEcCtD
Pralidoxime—Somnolence—Rufinamide—epilepsy syndrome	0.000877	0.00387	CcSEcCtD
Pralidoxime—Drowsiness—Lamotrigine—epilepsy syndrome	0.000874	0.00385	CcSEcCtD
Pralidoxime—Haemoglobin—Clonazepam—epilepsy syndrome	0.00086	0.00379	CcSEcCtD
Pralidoxime—Pain—Phenobarbital—epilepsy syndrome	0.000859	0.00379	CcSEcCtD
Pralidoxime—Haemorrhage—Clonazepam—epilepsy syndrome	0.000856	0.00377	CcSEcCtD
Pralidoxime—Haemoglobin—Phenytoin—epilepsy syndrome	0.000854	0.00377	CcSEcCtD
Pralidoxime—Dizziness—Primidone—epilepsy syndrome	0.000853	0.00376	CcSEcCtD
Pralidoxime—Haemorrhage—Phenytoin—epilepsy syndrome	0.00085	0.00375	CcSEcCtD
Pralidoxime—Vision blurred—Midazolam—epilepsy syndrome	0.000841	0.00371	CcSEcCtD
Pralidoxime—Headache—Amobarbital—epilepsy syndrome	0.000839	0.0037	CcSEcCtD
Pralidoxime—Agitation—Propofol—epilepsy syndrome	0.000838	0.00369	CcSEcCtD
Pralidoxime—Vision blurred—Levetiracetam—epilepsy syndrome	0.00083	0.00366	CcSEcCtD
Pralidoxime—Somnolence—Lacosamide—epilepsy syndrome	0.000823	0.00363	CcSEcCtD
Pralidoxime—Agitation—Midazolam—epilepsy syndrome	0.00082	0.00362	CcSEcCtD
Pralidoxime—Diplopia—Pregabalin—epilepsy syndrome	0.000814	0.00359	CcSEcCtD
Pralidoxime—Agitation—Levetiracetam—epilepsy syndrome	0.00081	0.00357	CcSEcCtD
Pralidoxime—Headache—Primidone—epilepsy syndrome	0.000808	0.00356	CcSEcCtD
Pralidoxime—Somnolence—Clobazam—epilepsy syndrome	0.000799	0.00352	CcSEcCtD
Pralidoxime—Nausea—Amobarbital—epilepsy syndrome	0.000795	0.00351	CcSEcCtD
Pralidoxime—Muscular weakness—Valproic Acid—epilepsy syndrome	0.000794	0.0035	CcSEcCtD
Pralidoxime—Haemoglobin—Lamotrigine—epilepsy syndrome	0.000788	0.00348	CcSEcCtD
Pralidoxime—Haemorrhage—Lamotrigine—epilepsy syndrome	0.000784	0.00346	CcSEcCtD
Pralidoxime—Agitation—Fosphenytoin—epilepsy syndrome	0.000781	0.00345	CcSEcCtD
Pralidoxime—Vision blurred—Vigabatrin—epilepsy syndrome	0.000781	0.00344	CcSEcCtD
Pralidoxime—Vision blurred—Diazepam—epilepsy syndrome	0.000769	0.00339	CcSEcCtD
Pralidoxime—Nausea—Primidone—epilepsy syndrome	0.000766	0.00338	CcSEcCtD
Pralidoxime—Agitation—Vigabatrin—epilepsy syndrome	0.000762	0.00336	CcSEcCtD
Pralidoxime—Agitation—Diazepam—epilepsy syndrome	0.00075	0.00331	CcSEcCtD
Pralidoxime—Diplopia—Gabapentin—epilepsy syndrome	0.000747	0.00329	CcSEcCtD
Pralidoxime—Tachycardia—Propofol—epilepsy syndrome	0.000726	0.0032	CcSEcCtD
Pralidoxime—Agitation—Felbamate—epilepsy syndrome	0.000726	0.0032	CcSEcCtD
Pralidoxime—Muscular weakness—Pregabalin—epilepsy syndrome	0.000718	0.00317	CcSEcCtD
Pralidoxime—Somnolence—Acetazolamide—epilepsy syndrome	0.000712	0.00314	CcSEcCtD
Pralidoxime—Headache—Trimethadione—epilepsy syndrome	0.000711	0.00313	CcSEcCtD
Pralidoxime—Tachycardia—Midazolam—epilepsy syndrome	0.000711	0.00313	CcSEcCtD
Pralidoxime—Agitation—Zonisamide—epilepsy syndrome	0.00071	0.00313	CcSEcCtD
Pralidoxime—Vision blurred—Clonazepam—epilepsy syndrome	0.000702	0.0031	CcSEcCtD
Pralidoxime—Drowsiness—Valproic Acid—epilepsy syndrome	0.000694	0.00306	CcSEcCtD
Pralidoxime—Vision blurred—Oxcarbazepine—epilepsy syndrome	0.000694	0.00306	CcSEcCtD
Pralidoxime—Agitation—Clonazepam—epilepsy syndrome	0.000685	0.00302	CcSEcCtD
Pralidoxime—Agitation—Phenytoin—epilepsy syndrome	0.00068	0.003	CcSEcCtD
Pralidoxime—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000677	0.00299	CcSEcCtD
Pralidoxime—Agitation—Oxcarbazepine—epilepsy syndrome	0.000676	0.00298	CcSEcCtD
Pralidoxime—Nausea—Trimethadione—epilepsy syndrome	0.000674	0.00297	CcSEcCtD
Pralidoxime—Vision blurred—Carbamazepine—epilepsy syndrome	0.000666	0.00294	CcSEcCtD
Pralidoxime—Dizziness—Phenobarbital—epilepsy syndrome	0.000665	0.00293	CcSEcCtD
Pralidoxime—Somnolence—Propofol—epilepsy syndrome	0.000662	0.00292	CcSEcCtD
Pralidoxime—Muscular weakness—Gabapentin—epilepsy syndrome	0.000659	0.0029	CcSEcCtD
Pralidoxime—Dizziness—Rufinamide—epilepsy syndrome	0.000652	0.00288	CcSEcCtD
Pralidoxime—Tachycardia—Diazepam—epilepsy syndrome	0.00065	0.00287	CcSEcCtD
Pralidoxime—Agitation—Carbamazepine—epilepsy syndrome	0.000649	0.00286	CcSEcCtD
Pralidoxime—Somnolence—Midazolam—epilepsy syndrome	0.000647	0.00285	CcSEcCtD
Pralidoxime—Vision blurred—Lamotrigine—epilepsy syndrome	0.000643	0.00284	CcSEcCtD
Pralidoxime—Somnolence—Levetiracetam—epilepsy syndrome	0.000639	0.00282	CcSEcCtD
Pralidoxime—Pain—Propofol—epilepsy syndrome	0.000636	0.00281	CcSEcCtD
Pralidoxime—Headache—Phenobarbital—epilepsy syndrome	0.00063	0.00278	CcSEcCtD
Pralidoxime—Tachycardia—Felbamate—epilepsy syndrome	0.000629	0.00277	CcSEcCtD
Pralidoxime—Diplopia—Topiramate—epilepsy syndrome	0.000628	0.00277	CcSEcCtD
Pralidoxime—Agitation—Lamotrigine—epilepsy syndrome	0.000627	0.00277	CcSEcCtD
Pralidoxime—Haemoglobin—Valproic Acid—epilepsy syndrome	0.000626	0.00276	CcSEcCtD
Pralidoxime—Haemorrhage—Valproic Acid—epilepsy syndrome	0.000623	0.00275	CcSEcCtD
Pralidoxime—Pain—Midazolam—epilepsy syndrome	0.000623	0.00275	CcSEcCtD
Pralidoxime—Headache—Rufinamide—epilepsy syndrome	0.000618	0.00272	CcSEcCtD
Pralidoxime—Somnolence—Fosphenytoin—epilepsy syndrome	0.000617	0.00272	CcSEcCtD
Pralidoxime—Tachycardia—Zonisamide—epilepsy syndrome	0.000616	0.00272	CcSEcCtD
Pralidoxime—Pain—Levetiracetam—epilepsy syndrome	0.000615	0.00271	CcSEcCtD
Pralidoxime—Dizziness—Lacosamide—epilepsy syndrome	0.000612	0.0027	CcSEcCtD
Pralidoxime—Somnolence—Vigabatrin—epilepsy syndrome	0.000601	0.00265	CcSEcCtD
Pralidoxime—Nausea—Phenobarbital—epilepsy syndrome	0.000597	0.00263	CcSEcCtD
Pralidoxime—Dizziness—Clobazam—epilepsy syndrome	0.000594	0.00262	CcSEcCtD
Pralidoxime—Tachycardia—Clonazepam—epilepsy syndrome	0.000593	0.00262	CcSEcCtD
Pralidoxime—Somnolence—Diazepam—epilepsy syndrome	0.000592	0.00261	CcSEcCtD
Pralidoxime—Tachycardia—Phenytoin—epilepsy syndrome	0.000589	0.0026	CcSEcCtD
Pralidoxime—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000586	0.00259	CcSEcCtD
Pralidoxime—Nausea—Rufinamide—epilepsy syndrome	0.000586	0.00258	CcSEcCtD
Pralidoxime—Headache—Lacosamide—epilepsy syndrome	0.00058	0.00256	CcSEcCtD
Pralidoxime—Pain—Vigabatrin—epilepsy syndrome	0.000578	0.00255	CcSEcCtD
Pralidoxime—Drowsiness—Gabapentin—epilepsy syndrome	0.000575	0.00254	CcSEcCtD
Pralidoxime—Somnolence—Felbamate—epilepsy syndrome	0.000573	0.00253	CcSEcCtD
Pralidoxime—Pain—Diazepam—epilepsy syndrome	0.000569	0.00251	CcSEcCtD
Pralidoxime—Haemoglobin—Pregabalin—epilepsy syndrome	0.000566	0.0025	CcSEcCtD
Pralidoxime—Haemorrhage—Pregabalin—epilepsy syndrome	0.000563	0.00248	CcSEcCtD
Pralidoxime—Headache—Clobazam—epilepsy syndrome	0.000563	0.00248	CcSEcCtD
Pralidoxime—Tachycardia—Carbamazepine—epilepsy syndrome	0.000563	0.00248	CcSEcCtD
Pralidoxime—Somnolence—Zonisamide—epilepsy syndrome	0.000561	0.00247	CcSEcCtD
Pralidoxime—Muscular weakness—Topiramate—epilepsy syndrome	0.000554	0.00244	CcSEcCtD
Pralidoxime—Pain—Felbamate—epilepsy syndrome	0.000551	0.00243	CcSEcCtD
Pralidoxime—Nausea—Lacosamide—epilepsy syndrome	0.00055	0.00243	CcSEcCtD
Pralidoxime—Tachycardia—Lamotrigine—epilepsy syndrome	0.000544	0.0024	CcSEcCtD
Pralidoxime—Somnolence—Clonazepam—epilepsy syndrome	0.000541	0.00238	CcSEcCtD
Pralidoxime—Somnolence—Phenytoin—epilepsy syndrome	0.000537	0.00237	CcSEcCtD
Pralidoxime—Somnolence—Oxcarbazepine—epilepsy syndrome	0.000534	0.00236	CcSEcCtD
Pralidoxime—Nausea—Clobazam—epilepsy syndrome	0.000534	0.00235	CcSEcCtD
Pralidoxime—Dizziness—Acetazolamide—epilepsy syndrome	0.00053	0.00234	CcSEcCtD
Pralidoxime—Pain—Clonazepam—epilepsy syndrome	0.00052	0.00229	CcSEcCtD
Pralidoxime—Haemorrhage—Gabapentin—epilepsy syndrome	0.000517	0.00228	CcSEcCtD
Pralidoxime—Pain—Oxcarbazepine—epilepsy syndrome	0.000514	0.00227	CcSEcCtD
Pralidoxime—Somnolence—Carbamazepine—epilepsy syndrome	0.000513	0.00226	CcSEcCtD
Pralidoxime—Vision blurred—Valproic Acid—epilepsy syndrome	0.000511	0.00225	CcSEcCtD
Pralidoxime—Headache—Acetazolamide—epilepsy syndrome	0.000502	0.00221	CcSEcCtD
Pralidoxime—Agitation—Valproic Acid—epilepsy syndrome	0.000499	0.0022	CcSEcCtD
Pralidoxime—Somnolence—Lamotrigine—epilepsy syndrome	0.000495	0.00218	CcSEcCtD
Pralidoxime—Pain—Carbamazepine—epilepsy syndrome	0.000493	0.00217	CcSEcCtD
Pralidoxime—Dizziness—Propofol—epilepsy syndrome	0.000492	0.00217	CcSEcCtD
Pralidoxime—Dizziness—Midazolam—epilepsy syndrome	0.000481	0.00212	CcSEcCtD
Pralidoxime—Pain—Lamotrigine—epilepsy syndrome	0.000476	0.0021	CcSEcCtD
Pralidoxime—Nausea—Acetazolamide—epilepsy syndrome	0.000476	0.0021	CcSEcCtD
Pralidoxime—Dizziness—Levetiracetam—epilepsy syndrome	0.000475	0.0021	CcSEcCtD
Pralidoxime—Headache—Propofol—epilepsy syndrome	0.000466	0.00206	CcSEcCtD
Pralidoxime—Vision blurred—Pregabalin—epilepsy syndrome	0.000462	0.00204	CcSEcCtD
Pralidoxime—Dizziness—Fosphenytoin—epilepsy syndrome	0.000459	0.00202	CcSEcCtD
Pralidoxime—Headache—Midazolam—epilepsy syndrome	0.000456	0.00201	CcSEcCtD
Pralidoxime—Agitation—Pregabalin—epilepsy syndrome	0.000451	0.00199	CcSEcCtD
Pralidoxime—Headache—Levetiracetam—epilepsy syndrome	0.00045	0.00199	CcSEcCtD
Pralidoxime—Dizziness—Vigabatrin—epilepsy syndrome	0.000447	0.00197	CcSEcCtD
Pralidoxime—ACHE—telencephalon—epilepsy syndrome	0.000443	0.121	CbGeAlD
Pralidoxime—Nausea—Propofol—epilepsy syndrome	0.000442	0.00195	CcSEcCtD
Pralidoxime—Dizziness—Diazepam—epilepsy syndrome	0.00044	0.00194	CcSEcCtD
Pralidoxime—Haemoglobin—Topiramate—epilepsy syndrome	0.000437	0.00193	CcSEcCtD
Pralidoxime—Headache—Fosphenytoin—epilepsy syndrome	0.000435	0.00192	CcSEcCtD
Pralidoxime—Haemorrhage—Topiramate—epilepsy syndrome	0.000435	0.00192	CcSEcCtD
Pralidoxime—Nausea—Midazolam—epilepsy syndrome	0.000432	0.00191	CcSEcCtD
Pralidoxime—Tachycardia—Valproic Acid—epilepsy syndrome	0.000432	0.00191	CcSEcCtD
Pralidoxime—Nausea—Levetiracetam—epilepsy syndrome	0.000427	0.00188	CcSEcCtD
Pralidoxime—Dizziness—Felbamate—epilepsy syndrome	0.000426	0.00188	CcSEcCtD
Pralidoxime—Vision blurred—Gabapentin—epilepsy syndrome	0.000424	0.00187	CcSEcCtD
Pralidoxime—Headache—Vigabatrin—epilepsy syndrome	0.000424	0.00187	CcSEcCtD
Pralidoxime—Dizziness—Zonisamide—epilepsy syndrome	0.000417	0.00184	CcSEcCtD
Pralidoxime—Headache—Diazepam—epilepsy syndrome	0.000417	0.00184	CcSEcCtD
Pralidoxime—Agitation—Gabapentin—epilepsy syndrome	0.000413	0.00182	CcSEcCtD
Pralidoxime—Nausea—Fosphenytoin—epilepsy syndrome	0.000412	0.00182	CcSEcCtD
Pralidoxime—Headache—Felbamate—epilepsy syndrome	0.000404	0.00178	CcSEcCtD
Pralidoxime—Dizziness—Clonazepam—epilepsy syndrome	0.000402	0.00177	CcSEcCtD
Pralidoxime—Nausea—Vigabatrin—epilepsy syndrome	0.000402	0.00177	CcSEcCtD
Pralidoxime—Dizziness—Phenytoin—epilepsy syndrome	0.000399	0.00176	CcSEcCtD
Pralidoxime—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000397	0.00175	CcSEcCtD
Pralidoxime—Nausea—Diazepam—epilepsy syndrome	0.000396	0.00174	CcSEcCtD
Pralidoxime—Headache—Zonisamide—epilepsy syndrome	0.000395	0.00174	CcSEcCtD
Pralidoxime—Somnolence—Valproic Acid—epilepsy syndrome	0.000394	0.00174	CcSEcCtD
Pralidoxime—Tachycardia—Pregabalin—epilepsy syndrome	0.000391	0.00172	CcSEcCtD
Pralidoxime—Nausea—Felbamate—epilepsy syndrome	0.000383	0.00169	CcSEcCtD
Pralidoxime—Dizziness—Carbamazepine—epilepsy syndrome	0.000381	0.00168	CcSEcCtD
Pralidoxime—Headache—Clonazepam—epilepsy syndrome	0.000381	0.00168	CcSEcCtD
Pralidoxime—Pain—Valproic Acid—epilepsy syndrome	0.000379	0.00167	CcSEcCtD
Pralidoxime—Headache—Phenytoin—epilepsy syndrome	0.000378	0.00167	CcSEcCtD
Pralidoxime—Headache—Oxcarbazepine—epilepsy syndrome	0.000376	0.00166	CcSEcCtD
Pralidoxime—Nausea—Zonisamide—epilepsy syndrome	0.000375	0.00165	CcSEcCtD
Pralidoxime—Dizziness—Lamotrigine—epilepsy syndrome	0.000368	0.00162	CcSEcCtD
Pralidoxime—Nausea—Clonazepam—epilepsy syndrome	0.000361	0.00159	CcSEcCtD
Pralidoxime—Headache—Carbamazepine—epilepsy syndrome	0.000361	0.00159	CcSEcCtD
Pralidoxime—Nausea—Phenytoin—epilepsy syndrome	0.000359	0.00158	CcSEcCtD
Pralidoxime—Tachycardia—Gabapentin—epilepsy syndrome	0.000358	0.00158	CcSEcCtD
Pralidoxime—Nausea—Oxcarbazepine—epilepsy syndrome	0.000357	0.00157	CcSEcCtD
Pralidoxime—Vision blurred—Topiramate—epilepsy syndrome	0.000357	0.00157	CcSEcCtD
Pralidoxime—Somnolence—Pregabalin—epilepsy syndrome	0.000356	0.00157	CcSEcCtD
Pralidoxime—Headache—Lamotrigine—epilepsy syndrome	0.000349	0.00154	CcSEcCtD
Pralidoxime—ACHE—medulla oblongata—epilepsy syndrome	0.000348	0.0953	CbGeAlD
Pralidoxime—Agitation—Topiramate—epilepsy syndrome	0.000348	0.00153	CcSEcCtD
Pralidoxime—Nausea—Carbamazepine—epilepsy syndrome	0.000342	0.00151	CcSEcCtD
Pralidoxime—Pain—Pregabalin—epilepsy syndrome	0.000342	0.00151	CcSEcCtD
Pralidoxime—Nausea—Lamotrigine—epilepsy syndrome	0.000331	0.00146	CcSEcCtD
Pralidoxime—Somnolence—Gabapentin—epilepsy syndrome	0.000326	0.00144	CcSEcCtD
Pralidoxime—ACHE—midbrain—epilepsy syndrome	0.000318	0.0871	CbGeAlD
Pralidoxime—Pain—Gabapentin—epilepsy syndrome	0.000314	0.00138	CcSEcCtD
Pralidoxime—ACHE—spinal cord—epilepsy syndrome	0.00031	0.085	CbGeAlD
Pralidoxime—Tachycardia—Topiramate—epilepsy syndrome	0.000301	0.00133	CcSEcCtD
Pralidoxime—Dizziness—Valproic Acid—epilepsy syndrome	0.000293	0.00129	CcSEcCtD
Pralidoxime—Headache—Valproic Acid—epilepsy syndrome	0.000277	0.00122	CcSEcCtD
Pralidoxime—Somnolence—Topiramate—epilepsy syndrome	0.000275	0.00121	CcSEcCtD
Pralidoxime—Dizziness—Pregabalin—epilepsy syndrome	0.000265	0.00117	CcSEcCtD
Pralidoxime—Pain—Topiramate—epilepsy syndrome	0.000264	0.00116	CcSEcCtD
Pralidoxime—Nausea—Valproic Acid—epilepsy syndrome	0.000263	0.00116	CcSEcCtD
Pralidoxime—Headache—Pregabalin—epilepsy syndrome	0.000251	0.00111	CcSEcCtD
Pralidoxime—ACHE—cerebellum—epilepsy syndrome	0.000246	0.0674	CbGeAlD
Pralidoxime—BCHE—brainstem—epilepsy syndrome	0.000245	0.0672	CbGeAlD
Pralidoxime—Dizziness—Gabapentin—epilepsy syndrome	0.000243	0.00107	CcSEcCtD
Pralidoxime—Nausea—Pregabalin—epilepsy syndrome	0.000238	0.00105	CcSEcCtD
Pralidoxime—BCHE—forebrain—epilepsy syndrome	0.000237	0.0648	CbGeAlD
Pralidoxime—Headache—Gabapentin—epilepsy syndrome	0.00023	0.00101	CcSEcCtD
Pralidoxime—ACHE—Monoamine Transport—TNF—epilepsy syndrome	0.000227	0.00197	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—PIGN—epilepsy syndrome	0.000224	0.00194	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—PIGT—epilepsy syndrome	0.000224	0.00194	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—SLC1A2—epilepsy syndrome	0.000224	0.00194	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—CHRNA7—epilepsy syndrome	0.000224	0.00194	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GRIK1—epilepsy syndrome	0.000224	0.00194	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—KCNMA1—epilepsy syndrome	0.000224	0.00194	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—SLC6A1—epilepsy syndrome	0.000222	0.00192	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—GRIN2A—epilepsy syndrome	0.000222	0.00192	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—GRIA1—epilepsy syndrome	0.000222	0.00192	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.00022	0.00191	CbGpPWpGaD
Pralidoxime—Nausea—Gabapentin—epilepsy syndrome	0.000218	0.000961	CcSEcCtD
Pralidoxime—BCHE—telencephalon—epilepsy syndrome	0.000218	0.0596	CbGeAlD
Pralidoxime—ACHE—ATF-2 transcription factor network—BCL2—epilepsy syndrome	0.000217	0.00188	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GABRB2—epilepsy syndrome	0.000214	0.00185	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ERN1—epilepsy syndrome	0.000214	0.00185	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—CHRNA4—epilepsy syndrome	0.000214	0.00185	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—KCNJ11—epilepsy syndrome	0.000214	0.00185	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GRIK2—epilepsy syndrome	0.000214	0.00185	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—SLC1A3—epilepsy syndrome	0.000214	0.00185	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GAD2—epilepsy syndrome	0.000211	0.00183	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—CHRNB2—epilepsy syndrome	0.00021	0.00182	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—GOSR2—epilepsy syndrome	0.000205	0.00178	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GAD1—epilepsy syndrome	0.000205	0.00178	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—AGT—epilepsy syndrome	0.000204	0.00177	CbGpPWpGaD
Pralidoxime—Dizziness—Topiramate—epilepsy syndrome	0.000204	0.0009	CcSEcCtD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.000202	0.00175	CbGpPWpGaD
Pralidoxime—ACHE—brain—epilepsy syndrome	0.0002	0.0547	CbGeAlD
Pralidoxime—BCHE—Neuronal System—KCNMA1—epilepsy syndrome	0.0002	0.00173	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.000197	0.00171	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GABBR1—epilepsy syndrome	0.000195	0.00169	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.000194	0.00168	CbGpPWpGaD
Pralidoxime—Headache—Topiramate—epilepsy syndrome	0.000193	0.000853	CcSEcCtD
Pralidoxime—ACHE—Peptide hormone metabolism—POMC—epilepsy syndrome	0.000193	0.00167	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ERN1—epilepsy syndrome	0.000191	0.00165	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—CHRNA4—epilepsy syndrome	0.000191	0.00165	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—KCNJ11—epilepsy syndrome	0.00019	0.00165	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—SLC1A3—epilepsy syndrome	0.00019	0.00165	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GRIK2—epilepsy syndrome	0.00019	0.00165	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GRIN2A—epilepsy syndrome	0.00019	0.00165	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—SLC6A1—epilepsy syndrome	0.00019	0.00165	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GRIA1—epilepsy syndrome	0.00019	0.00165	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	0.000188	0.00163	CbGpPWpGaD
Pralidoxime—ACHE—ATF-2 transcription factor network—JUN—epilepsy syndrome	0.000186	0.00161	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	0.000185	0.0016	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	0.000184	0.00159	CbGpPWpGaD
Pralidoxime—Nausea—Topiramate—epilepsy syndrome	0.000183	0.000809	CcSEcCtD
Pralidoxime—BCHE—Neuronal System—GAD1—epilepsy syndrome	0.000183	0.00158	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—CHRNB2—epilepsy syndrome	0.00018	0.00156	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.00018	0.00156	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	0.00018	0.00156	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	0.000178	0.00154	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.000176	0.00153	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GABBR1—epilepsy syndrome	0.000174	0.00151	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—NEU1—epilepsy syndrome	0.000174	0.00151	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—EIF2AK3—epilepsy syndrome	0.000174	0.00151	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.000173	0.0015	CbGpPWpGaD
Pralidoxime—BCHE—Peptide hormone metabolism—POMC—epilepsy syndrome	0.000172	0.00149	CbGpPWpGaD
Pralidoxime—BCHE—medulla oblongata—epilepsy syndrome	0.000171	0.0468	CbGeAlD
Pralidoxime—ACHE—Metabolism—CA13—epilepsy syndrome	0.000171	0.00148	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GRIA1—epilepsy syndrome	0.00017	0.00147	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—SLC6A1—epilepsy syndrome	0.00017	0.00147	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—GRIN2A—epilepsy syndrome	0.00017	0.00147	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	0.000164	0.00142	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—CHRNA4—epilepsy syndrome	0.000164	0.00142	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—PIGA—epilepsy syndrome	0.000162	0.0014	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—TPP1—epilepsy syndrome	0.000162	0.0014	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—CHRNB2—epilepsy syndrome	0.000161	0.00139	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	0.00016	0.00139	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	0.000158	0.00137	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.000157	0.00136	CbGpPWpGaD
Pralidoxime—BCHE—midbrain—epilepsy syndrome	0.000156	0.0428	CbGeAlD
Pralidoxime—BCHE—Metabolism of proteins—EIF2AK3—epilepsy syndrome	0.000155	0.00135	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—NEU1—epilepsy syndrome	0.000155	0.00135	CbGpPWpGaD
Pralidoxime—BCHE—spinal cord—epilepsy syndrome	0.000152	0.0418	CbGeAlD
Pralidoxime—BCHE—Metabolism—CA13—epilepsy syndrome	0.000152	0.00132	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—EIF2B5—epilepsy syndrome	0.000152	0.00132	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	0.00015	0.0013	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	0.000149	0.00129	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	0.000147	0.00128	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—CHRNA4—epilepsy syndrome	0.000146	0.00127	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—PIGA—epilepsy syndrome	0.000144	0.00125	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—TPP1—epilepsy syndrome	0.000144	0.00125	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ADD1—epilepsy syndrome	0.000144	0.00125	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—BCHE—epilepsy syndrome	0.000144	0.00125	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—DLG4—epilepsy syndrome	0.000141	0.00122	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—GRIN2B—epilepsy syndrome	0.000138	0.00119	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.000138	0.00119	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—PLCB1—epilepsy syndrome	0.000136	0.00118	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—EIF2B5—epilepsy syndrome	0.000136	0.00118	CbGpPWpGaD
Pralidoxime—BCHE—head—epilepsy syndrome	0.000136	0.0371	CbGeAlD
Pralidoxime—ACHE—Metabolism of proteins—ST3GAL3—epilepsy syndrome	0.000135	0.00117	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PDXK—epilepsy syndrome	0.000129	0.00112	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—FAR1—epilepsy syndrome	0.000129	0.00112	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—L2HGDH—epilepsy syndrome	0.000129	0.00112	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GLUD1—epilepsy syndrome	0.000129	0.00112	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ADK—epilepsy syndrome	0.000129	0.00112	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CERS1—epilepsy syndrome	0.000129	0.00112	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ST3GAL5—epilepsy syndrome	0.000129	0.00112	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ADD1—epilepsy syndrome	0.000129	0.00112	CbGpPWpGaD
Pralidoxime—BCHE—nervous system—epilepsy syndrome	0.000128	0.0352	CbGeAlD
Pralidoxime—BCHE—Neuronal System—DLG4—epilepsy syndrome	0.000126	0.00109	CbGpPWpGaD
Pralidoxime—BCHE—central nervous system—epilepsy syndrome	0.000124	0.0339	CbGeAlD
Pralidoxime—BCHE—Neuronal System—GRIN2B—epilepsy syndrome	0.000123	0.00106	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ATP6AP2—epilepsy syndrome	0.000123	0.00106	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.000123	0.00106	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—PLCB1—epilepsy syndrome	0.000121	0.00105	CbGpPWpGaD
Pralidoxime—BCHE—cerebellum—epilepsy syndrome	0.000121	0.0331	CbGeAlD
Pralidoxime—BCHE—Metabolism of proteins—ST3GAL3—epilepsy syndrome	0.00012	0.00104	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NHLRC1—epilepsy syndrome	0.000118	0.00103	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PNPO—epilepsy syndrome	0.000118	0.00103	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—EPM2A—epilepsy syndrome	0.000118	0.00103	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GAMT—epilepsy syndrome	0.000118	0.00103	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—FAR1—epilepsy syndrome	0.000116	0.001	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CERS1—epilepsy syndrome	0.000116	0.001	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PDXK—epilepsy syndrome	0.000116	0.001	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GLUD1—epilepsy syndrome	0.000116	0.001	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—L2HGDH—epilepsy syndrome	0.000116	0.001	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ADK—epilepsy syndrome	0.000116	0.001	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ST3GAL5—epilepsy syndrome	0.000115	0.001	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	0.000113	0.000981	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—QDPR—epilepsy syndrome	0.00011	0.000955	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CA4—epilepsy syndrome	0.00011	0.000955	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ATP6AP2—epilepsy syndrome	0.000109	0.000949	CbGpPWpGaD
Pralidoxime—ACHE—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	0.000107	0.000926	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—EPM2A—epilepsy syndrome	0.000106	0.000916	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GAMT—epilepsy syndrome	0.000106	0.000916	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NHLRC1—epilepsy syndrome	0.000106	0.000916	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PNPO—epilepsy syndrome	0.000106	0.000916	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—COX3—epilepsy syndrome	0.000104	0.000898	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	9.88e-05	0.000857	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CA4—epilepsy syndrome	9.82e-05	0.000852	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—QDPR—epilepsy syndrome	9.82e-05	0.000852	CbGpPWpGaD
Pralidoxime—BCHE—brain—epilepsy syndrome	9.82e-05	0.0269	CbGeAlD
Pralidoxime—ACHE—Metabolism—PFKL—epilepsy syndrome	9.81e-05	0.000851	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—KCNB1—epilepsy syndrome	9.81e-05	0.000851	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLCO1A2—epilepsy syndrome	9.81e-05	0.000851	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CACNA2D2—epilepsy syndrome	9.81e-05	0.000851	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC6A8—epilepsy syndrome	9.81e-05	0.000851	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	9.59e-05	0.000832	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	9.53e-05	0.000827	CbGpPWpGaD
Pralidoxime—BCHE—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	9.53e-05	0.000826	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—COX3—epilepsy syndrome	9.23e-05	0.000801	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—UPB1—epilepsy syndrome	8.98e-05	0.000778	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NEU1—epilepsy syndrome	8.98e-05	0.000778	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ATIC—epilepsy syndrome	8.98e-05	0.000778	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	8.93e-05	0.000774	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CACNA2D2—epilepsy syndrome	8.75e-05	0.000759	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC6A8—epilepsy syndrome	8.75e-05	0.000759	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—KCNB1—epilepsy syndrome	8.75e-05	0.000759	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLCO1A2—epilepsy syndrome	8.75e-05	0.000759	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PFKL—epilepsy syndrome	8.75e-05	0.000759	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HSD17B4—epilepsy syndrome	8.64e-05	0.000749	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	8.56e-05	0.000742	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	8.5e-05	0.000738	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	8.47e-05	0.000735	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GBE1—epilepsy syndrome	8.34e-05	0.000724	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PPP1R3C—epilepsy syndrome	8.34e-05	0.000724	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—EIF2S1—epilepsy syndrome	8.29e-05	0.000719	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—ACTB—epilepsy syndrome	8.19e-05	0.00071	CbGpPWpGaD
Pralidoxime—ACHE—Neuronal System—PRKCB—epilepsy syndrome	8.18e-05	0.00071	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.16e-05	0.000707	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	8.05e-05	0.000698	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ATIC—epilepsy syndrome	8.01e-05	0.000694	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NEU1—epilepsy syndrome	8.01e-05	0.000694	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—UPB1—epilepsy syndrome	8.01e-05	0.000694	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ASAH1—epilepsy syndrome	7.85e-05	0.00068	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HSD17B4—epilepsy syndrome	7.71e-05	0.000669	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—STXBP1—epilepsy syndrome	7.63e-05	0.000662	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	7.47e-05	0.000648	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PPP1R3C—epilepsy syndrome	7.44e-05	0.000646	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GBE1—epilepsy syndrome	7.44e-05	0.000646	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALAD—epilepsy syndrome	7.44e-05	0.000645	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—NT5E—epilepsy syndrome	7.44e-05	0.000645	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—EIF2S1—epilepsy syndrome	7.39e-05	0.000641	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—ACTB—epilepsy syndrome	7.3e-05	0.000633	CbGpPWpGaD
Pralidoxime—BCHE—Neuronal System—PRKCB—epilepsy syndrome	7.3e-05	0.000633	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	7.26e-05	0.00063	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CACNA1A—epilepsy syndrome	7.09e-05	0.000615	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALDH7A1—epilepsy syndrome	7.09e-05	0.000615	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—BCHE—epilepsy syndrome	7.05e-05	0.000611	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ASAH1—epilepsy syndrome	7e-05	0.000607	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ST3GAL3—epilepsy syndrome	6.94e-05	0.000602	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—STXBP1—epilepsy syndrome	6.81e-05	0.000591	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ADSL—epilepsy syndrome	6.8e-05	0.00059	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GLUL—epilepsy syndrome	6.67e-05	0.000579	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—NT5E—epilepsy syndrome	6.63e-05	0.000575	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALAD—epilepsy syndrome	6.63e-05	0.000575	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CACNA1D—epilepsy syndrome	6.55e-05	0.000568	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	6.51e-05	0.000565	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	6.34e-05	0.00055	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALDH7A1—epilepsy syndrome	6.33e-05	0.000549	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CACNA1A—epilepsy syndrome	6.33e-05	0.000549	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ST3GAL3—epilepsy syndrome	6.19e-05	0.000537	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—PLAUR—epilepsy syndrome	6.13e-05	0.000532	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TXNRD1—epilepsy syndrome	6.12e-05	0.000531	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ADSL—epilepsy syndrome	6.07e-05	0.000526	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GLUL—epilepsy syndrome	5.95e-05	0.000516	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AQP1—epilepsy syndrome	5.95e-05	0.000516	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CACNA1D—epilepsy syndrome	5.84e-05	0.000507	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.71e-05	0.000495	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—PLAUR—epilepsy syndrome	5.47e-05	0.000474	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TXNRD1—epilepsy syndrome	5.46e-05	0.000474	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	5.43e-05	0.000471	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—KCNJ11—epilepsy syndrome	5.38e-05	0.000466	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CHRM3—epilepsy syndrome	5.38e-05	0.000466	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AQP1—epilepsy syndrome	5.3e-05	0.00046	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.09e-05	0.000442	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.01e-05	0.000434	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.91e-05	0.000426	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CHRM3—epilepsy syndrome	4.8e-05	0.000416	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—KCNJ11—epilepsy syndrome	4.8e-05	0.000416	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.47e-05	0.000387	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCG2—epilepsy syndrome	4.38e-05	0.00038	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.38e-05	0.00038	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—AGT—epilepsy syndrome	4.33e-05	0.000375	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2C19—epilepsy syndrome	4.27e-05	0.00037	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP11A1—epilepsy syndrome	4.25e-05	0.000368	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.21e-05	0.000366	CbGpPWpGaD
Pralidoxime—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.05e-05	0.000351	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCG2—epilepsy syndrome	3.91e-05	0.000339	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—AGT—epilepsy syndrome	3.86e-05	0.000335	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.84e-05	0.000333	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CYP2D6—epilepsy syndrome	3.83e-05	0.000332	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2C19—epilepsy syndrome	3.81e-05	0.000331	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP11A1—epilepsy syndrome	3.79e-05	0.000328	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.76e-05	0.000326	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ADRA2A—epilepsy syndrome	3.65e-05	0.000316	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—POMC—epilepsy syndrome	3.64e-05	0.000316	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—BCHE—epilepsy syndrome	3.63e-05	0.000315	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of proteins—CCL2—epilepsy syndrome	3.56e-05	0.000309	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—SLC2A1—epilepsy syndrome	3.46e-05	0.000301	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.43e-05	0.000297	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PLCB1—epilepsy syndrome	3.43e-05	0.000297	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CYP2D6—epilepsy syndrome	3.42e-05	0.000296	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—TH—epilepsy syndrome	3.41e-05	0.000296	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.36e-05	0.000292	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ADRA2A—epilepsy syndrome	3.25e-05	0.000282	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—POMC—epilepsy syndrome	3.25e-05	0.000282	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of proteins—CCL2—epilepsy syndrome	3.18e-05	0.000276	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—SLC2A1—epilepsy syndrome	3.09e-05	0.000268	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PLCB1—epilepsy syndrome	3.06e-05	0.000265	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—TH—epilepsy syndrome	3.05e-05	0.000264	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3e-05	0.00026	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—HMOX1—epilepsy syndrome	2.85e-05	0.000247	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—CAT—epilepsy syndrome	2.81e-05	0.000244	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ABCB1—epilepsy syndrome	2.74e-05	0.000237	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—GPX1—epilepsy syndrome	2.54e-05	0.000221	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—HMOX1—epilepsy syndrome	2.54e-05	0.000221	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—CAT—epilepsy syndrome	2.51e-05	0.000218	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ABCB1—epilepsy syndrome	2.44e-05	0.000212	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—GPX1—epilepsy syndrome	2.27e-05	0.000197	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AGT—epilepsy syndrome	2.23e-05	0.000193	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—APOE—epilepsy syndrome	2.18e-05	0.00019	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AGT—epilepsy syndrome	1.99e-05	0.000173	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—APOE—epilepsy syndrome	1.95e-05	0.000169	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—POMC—epilepsy syndrome	1.88e-05	0.000163	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—ALB—epilepsy syndrome	1.71e-05	0.000148	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—POMC—epilepsy syndrome	1.67e-05	0.000145	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—ALB—epilepsy syndrome	1.53e-05	0.000132	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—PTGS2—epilepsy syndrome	1.5e-05	0.00013	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—PTGS2—epilepsy syndrome	1.34e-05	0.000116	CbGpPWpGaD
Pralidoxime—ACHE—Metabolism—AKT1—epilepsy syndrome	7.52e-06	6.53e-05	CbGpPWpGaD
Pralidoxime—BCHE—Metabolism—AKT1—epilepsy syndrome	6.71e-06	5.82e-05	CbGpPWpGaD
